4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-004722
Chief Financial Officer sold 40,313 shares at an average $49.44 ($1,992,925)
- Chief Financial Officer acquired 33,351 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…